Microbiota Biomarkers for Lung Cancer
Open Access
- 27 February 2021
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 11 (3) , 407
Abstract
Non-small cell lung cancer (NSCLC) is the number one cancer killer and its early detection can reduce mortality. Accumulating evidences suggest an etiopathogenic role of microorganisms in lung tumorigenesis. Certain bacteria are found to be associated with NSCLC. Herein we evaluated the potential use of microbiome as biomarkers for the early detection of NSCLC. We used droplet digital PCR to analyze 25 NSCLC-associated bacterial genera in 31 lung tumor and the paired noncancerous lung tissues and sputum of 17 NSCLC patients and ten cancer-free smokers. Of the bacterial genera, four had altered abundances in lung tumor tissues, while five were aberrantly abundant in sputum of NSCLC patients compared with their normal counterparts (all p < 0.05). Acidovorax and Veillonella were further developed as a panel of sputum biomarkers that could diagnose lung squamous cell carcinoma (SCC) with 80% sensitivity and 89% specificity. The use of Capnocytophaga as a sputum biomarker identified lung adenocarcinoma (AC) with 72% sensitivity and 85% specificity. The use of Acidovorax as a sputum biomarker had 63% sensitivity and 96% specificity for distinguishing between SCC and AC, the two major types of NSCLC. The sputum biomarkers were further validated for the diagnostic values in a different cohort of 69 NSCLC cases and 79 cancer-free controls. Sputum microbiome might provide noninvasive biomarkers for the early detection and classification of NSCLC.Keywords
Funding Information
- National Institutes of Health (1UH2CA251139-01)
This publication has 70 references indexed in Scilit:
- Evaluation of lung flute in sputum samples for molecular analysis of lung cancerClinical and Translational Medicine, 2013
- Quantification of Plasma miRNAs by Digital PCR for Cancer DiagnosisBiomarker Insights, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- A Panel of Sputum-Based Genomic Marker for Early Detection of Lung CancerCancer Prevention Research, 2010
- Early detection of lung adenocarcinoma in sputum by a panel of microRNA markersInternational Journal of Cancer, 2010
- Altered miRNA expression in sputum for diagnosis of non-small cell lung cancerLung Cancer, 2010
- Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancerLung Cancer, 2009
- Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancerLaboratory Investigation, 2008
- Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung CancerClinical Cancer Research, 2007
- Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancerCancer Detection Prevention, 2004